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isolates of the Beijing and east-
African indian lineage induce 
fundamentally different host 
responses in mice compared to 
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Substantial differences exist in virulence among Mycobacterium tuberculosis strains in preclinical tB 
models. In this study we show how virulence affects host responses in mice during the first four weeks 
of infection with a mycobacterial strain belonging to the Beijing, east-African-indian or euro-American 
lineage. BALB/c mice were infected with clinical isolates of the Beijing-1585 strain or the East-African 
Indian (EAI)-1627 strain and host responses were compared to mice infected with the non-clinical 
H37Rv strain of the Euro-American lineage. We found that H37Rv induced a ‘classical’ T-cell influx with 
high ifn-γ levels, while Beijing-1585 and EAI-1627 induced an influx of B-cells into the lungs together 
with elevated pulmonary IL-4 protein levels. Myeloid cells in the lungs appeared functionally impaired 
upon infection with Beijing-1585 and EAI-1627 with reduced iNOS and IL-12 expression levels compared 
to H37Rv infection. This impairment might be related to significantly reduced expression in the bone 
marrow of ifn-γ, tnf-α and ifn-β in mice infected with Beijing-1585 and EAI-1627, which could be 
detected from the third day post infection onwards. Our findings suggest that increased virulence of 
two clinical isolates compared to H37Rv is associated with a fundamentally different systemic immune 
response, which already can be detected early during infection.
Tuberculosis (TB) is a leading cause of death among infectious diseases worldwide and claimed more victims in 
2017 than HIV and malaria combined1. While global efforts have resulted in a steady decline in TB-related deaths 
over the years, new threats present themselves in the form of drug resistance and the emergence of more virulent 
Mycobacterium tuberculosis (Mtb) genotypes1–3.
Most TB cases are caused by modern lineage mycobacterial strains of the East Asian/Beijing lineage, the 
East-African Indian lineage and the Euro-American lineage2,4,5. Mycobacterial strains belonging to the Beijing 
genotype particularly have shown an aggressive global spread over the last century and have been associated with 
higher rates of treatment failure and disease relapse compared to other genotypes6–12. An important reason for the 
clinical impact of the Beijing genotypes, seems to be their increased capacity to acquire drug resistance13. A less 
well-defined characteristic concerns their hypervirulence14–16.
In preclinical TB models, virulent Beijing strains cause higher mycobacterial loads, more lung damage and 
earlier mortality compared to strains from other lineages15,17,18. Mechanistic studies have suggested that Beijing 
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strains have enhanced capacity to inhibit protective immunity in the lungs through induction of higher levels of 
type-I interferons, leading to lower IL-12 and TNF-α levels and reduced T-cell activation19,20. Increased Beijing 
virulence also has been attributed to bacterial phenolic glycolipid (PGL), which suppresses the production of 
IL-12, IL-6 and TNF-α by host immune cells21,22. Lastly, Beijing strains may induce a stronger regulatory T-cell 
response compared to other strains, thereby down-regulating protective immunity17,23.
In the current study we evaluate the host response during acute infection against the virulent Beijing-1585 
strain. This strain has previously demonstrated similar infection and mortality kinetics as other virulent Beijing 
strains18,24. Furthermore, Beijing-1585 was found associated with drug resistance and treatment failure18,25. 
We compare Beijing-1585 with the East-African/Indian (EAI)-1627 strain, that displays similar virulence as 
Beijing-1585 in our model18, and with the less virulent H37Rv strain belonging to the Euro-American lineage26.
Previous studies in our BALB/c mouse TB model showed that mice infected with H37Rv reach maximal 
mycobacterial loads and start developing progressive pneumonia 28 days post infection (dpi). Next, they enter 
a phase of chronic infection and become moribund between 22 and 38 weeks post infection26. In contrast, mice 
infected with Beijing-1585 or EAI-1627 reach peak infection at 14 dpi with histopathological signs of pneumonia 
comparable to H37Rv at 28 dpi and rapidly become moribund between three to five weeks post infection if left 
untreated26,27. In this study we aim to identify the differences in underlying host responses that might contribute 
to this marked difference in virulence.
Results
Infection with Beijing-1585 or EAI-1627 results in higher mycobacterial loads compared to 
H37Rv. After intratracheal infection of BALB/c mice with Mycobacterium tuberculosis (Mtb), we found no 
significant differences in mycobacterial load between Beijing-1585, EAI-1627 and H37Rv at 1 day post infection 
(dpi) and 3 dpi, indicating that all groups received a similar inoculum of mycobacteria (Fig. 1A). At 7 dpi, mice 
infected with Beijing-1585 had significantly higher mycobacterial loads and at 14 dpi, Beijing-1585 and EAI-1627 
caused almost 2 log higher loads than H37Rv. Mycobacterial loads for H37Rv at peak infection (28 dpi) were still 
one log value lower than those observed for Beijing-1585 and EAI-1627 at 14 dpi. These findings are in agreement 
with our and others’ previous studies monitoring mycobacterial loads for Beijing strains and H37Rv15,28,29.
To assess whether the higher mycobacterial loads in the lungs caused by Beijing-1585 and EAI-1627 were 
associated with more rapid dissemination to other organs, we determined mycobacterial loads in the spleen 
(Fig. 1B). No significant differences in culture positivity rate were found between strains, but mycobacterial loads 
in the spleens of mice infected with Beijing-1585 were higher at 7 dpi and 14 dpi compared to other groups.
Beijing-1585 and EAI-1627 induce lung influx of B-cells, while H37Rv induces T-cell influx. To 
explore whether the distinct in vivo mycobacterial growth profiles in our model correlated with differences in 
adaptive immune responses, we evaluated the numbers of B- and T-cells recruited to the lungs by the three 
different strains. Most notably, Beijing-1585 and EAI-1627 induced a strong influx of CD45R+ cells, identifying 
B-lymphocytes, at 14 dpi, which was not observed for H37Rv at either 14 dpi or 28 dpi (Fig. 2A). In contrast, 
H37Rv induced the recruitment of CD4+ and CD8+ T-cells at 28 dpi, which in turn was not observed upon infec-
tion with the clinical strains (Fig. 2B,C). Despite the marked T-cell increase in the H37Rv group at 28 dpi, Foxp3+ 
regulatory T-cell percentages of total lung single cell suspension remained lower compared to Beijing-1585 and 
EAI-1627 at 14 dpi (Fig. 2D). The latter strains show a marked difference in FoxP3+ Treg at 14 dpi, where only 
mice infected with EAI-1627 show an elevated Treg level above background.
The associated cytokine protein levels in the lungs for each time point and genotype strain are shown in Fig. 3. 
In accordance with the increase in B-cells, Beijing-1585- and EAI-1627-infected mice showed elevated protein 
Figure 1. Mycobacterial loads in lungs and spleen. (A) Mycobacterial loads in the lungs after intratracheal 
infection with Beijing-1585 (black bars), EAI-1627 (open bars) or H37Rv (grey bars). After 14 days 
Beijing-1585- and EAI-1627-infected mice rapidly become moribund, therefore no later analyses for these 
strains are possible. (B) Mycobacterial loads in the spleen. Three mice were used for each group at 1 dpi and 6 
mice for each group at the remaining time points. The numbers above the bars indicate the number of mice out 
of n = 6 in total with positive cultures. Inoculum sizes were 1.0.105 CFU for Beijing, 1.3.105 CFU for EAI and 
1.8.105 CFU for H37Rv. *p < 0.05 **p < 0.01 ***p < 0.001 after Bonferroni correction.
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levels of IL-4 at 14 dpi. These were 4–5 fold higher than IL-4 levels observed for H37Rv at 14 or 28 dpi (Fig. 3A). 
Although Beijing-1585 and EAI-1627 also caused elevated protein levels of IFN-γ and IL-17a at 14 dpi, these 
remained 2-fold and 6-fold lower, respectively, compared to the H37Rv group at 28 dpi (Fig. 3B,C).
The TNF-α protein levels in the lungs closely correlated with strain-dependent differences in mycobacterial 
loads over time. At 7 dpi, TNF-α levels were significantly induced only in mice infected with Beijing-1585- and 
EAI-1627, which were almost 2-fold higher at 14 dpi compared to H37Rv at 28 dpi (Fig. 3D). This is in line with 
the role of TNF-α as general inflammation marker. In support of this, the inflammation marker IL-6 showed 
similar kinetics as TNF-α over time (Fig. S1). IL-10 and IL-23 levels were also measured in the lung homogenates 
but were below the limit of detection of our assay (data not shown). Quantitative PCR measurements of IFN-γ, 
IL-17a TNF-α, IL-6 in the lungs were performed with outcomes comparable to those at protein level as shown in 
Fig. 3 (Fig. S2). IL-10 expression levels were above the lower limit of detection but did not show strain-specific 
differences (Fig. S2).
Beijing-1585 and EAI-1627 induce a qualitatively impaired myeloid response compared to 
H37Rv. The observed differences in lymphoid cell responses and cytokine levels raised the question whether 
CD11b+ myeloid cell influxes in the lungs might also vary between mice infected with different Mtb strains. Lung 
polymorphonuclear granulocyte (PMN) percentages were increased in the Beijing-1585 and EAI-1627 group 
compared to H37Rv at 7 dpi and 14 dpi (Fig. 4A), which was in line with the elevated mycobacterial loads and 
inflammation markers TNF-α and IL-6 at these time points. However, at 28 dpi the PMN frequency in the H37Rv 
group was comparable with that in the Beijing-1585 group and EAI-1627 group at 14 dpi.
Inflammatory macrophage/dendritic cell (iM/DC; CD11b+Ly6CintCD11chigh) influx showed a similar profile 
as PMN (Fig. 4B). Monocyte-like cells (CD11b+Ly6ChighCD11clow) were present to a lesser extent than PMN and 
iM/DC, and were only higher in the EAI-1627 group at 14 dpi compared to the H37Rv group at 28 dpi (Fig. 4C). 
Figure 2. Lymphoid cell populations in the lungs of mice infected with different Mtb strains. Lymphoid cells 
were determined in the lungs of mice infected with Beijing-1585 (black bars), EAI-1627 (open bars) or H37Rv 
(grey bars) and compared to uninfected control mice (HC, striped bars). Gating strategies are shown in Fig. S5. 
(A) B-cells, identified based on scatterplot and high level CD45R expression, are significantly higher in number 
for Beijing-1585- and EAI-1627-infected mice at 14 dpi compared with H37Rv at 14 and 28 dpi. (B,C) Only 
H37Rv infection induces an increase in both CD4+ and CD8+ T-cells at 28 dpi. (D) Despite the increase in 
T-cells caused by H37Rv infection at 28 dpi, Foxp3+ regulatory T-cells are significantly lower compared to 
Beijing-1585- and EAI-1627-infected mice at 14 dpi. Gating strategies were similar as described previously51. 
N = 6 mice per group per time point, *p < 0.05, **p < 0.01, ***p < 0.001 after Bonferroni correction. Data are 
shown as % of total lung single cell suspension.
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Alveolar macrophages (AM) were reduced over time in all groups, associated with inflammatory cell influx, but 
most prominently at 14 dpi in the Beijing-1585 and EAI-1627 groups compared to the H37Rv group (Fig. 4D). 
We also evaluated lung eosinophils in each group since these cells are known IL-4 producers, but levels of these 
cells were not elevated in the Beijing-1585 and EAI-1627 groups compared to the H37Rv group at any time point 
evaluated (Fig. S3).
The AM and iM/DC are important cellular sources of IL-12 in the lungs30, which is essential for initiation of 
T-cell responses31. Therefore, we measured the expression of IL-12p35 and IL-12p40. Most notably, Beijing-1585 
caused the strongest down-regulation of IL-12p35 in the lungs compared to uninfected control mice and did not 
induce any IL-12p40 expression at all time points evaluated (Fig. 5A,B).
To investigate induction of putative bactericidal activity30,32 we measured the expression of inducible nitric 
oxide synthase (iNOS), typically inducible by IFN-γ and TNF-α, in both infiltrating iM/DC and the lung-resident 
AM at each time point. The AM from mice infected with the clinical strains essentially failed to up-regulate iNOS 
at any point during the course of infection (Fig. 5C). In contrast, iNOS expression was already significantly higher 
in AM from H37Rv-infected mice at 3 dpi and its expression continued to increase up to 14 dpi.
The iM/DC in lungs of mice infected with Beijing-1585 or EAI-1627 also showed significantly lower iNOS 
expression compared to H37Rv-infected mice at all time points (Fig. 5D). At 14 dpi, when IFN-γ and TNF-α 
levels were high in the lungs of mice from the Beijing-1585 and EAI-1627 group (Fig. 3C), iNOS expression by 
iM/DC was increased accordingly. Nevertheless, iNOS expression by iM/DC in H37Rv-infected mice was sig-
nificantly higher at 14 dpi despite lower levels of IFN-γ and TNF-α in the lungs compared to Beijing-1585- and 
EAI-1627-infected mice. iNOS expression by iM/DC in H37Rv-infected mice increased even further at 28 dpi.
Infection with Beijing-1585 induces less inflammatory cytokines in bone marrow compared to 
H37Rv. The differential induction of iNOS in infiltrating iM/DC might be caused by distinct local inflamma-
tory or inhibitory conditions. Alternatively, cells might be differently primed at an earlier developmental stage. 
Therefore, we determined cytokine mRNA expression in the bone marrow in the course of infection. Similar to 
the lungs, IL-12p35 mRNA expression in the bone marrow was down-regulated most effectively by Beijing-1585 
infection compared to uninfected mice at all time points evaluated (Fig. 6A). Interestingly, Beijing-1585 infection 
Figure 3. Cytokine protein levels in the lungs of mice infected with different Mtb strains. Protein levels were 
determined in lung tissue homogenates of mice infected with Beijing-1585 (black bars), EAI-1627 (open bars) 
or H37Rv (grey bars). (A) IL-4 levels are 4–5 fold higher for Beijing-1585 and EAI-1627 at 14 dpi compared to 
H37Rv at 14 dpi or 28 dpi. (B) IFN-γ levels are elevated for Beijing-1585 and EAI-1627 at 14 dpi, but are 2-fold 
lower compared to H37Rv at 28 dpi. (C) Beijing-1585 and EAI-1627 induced circa 7-fold lower levels of IL-17a 
at 14 dpi compared to H37Rv at 28 dpi. (D) TNF-α levels are circa 2-fold higher for Beijing-1585 and EAI-1627 
at 14 dpi compared to H37Rv at 28 dpi. N = 5 mice per group per time point for Beijing-1585 and H37Rv and 
n = 4 mice for EAI, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 after Bonferroni correction.
5Scientific RepoRtS |         (2019) 9:19922  | https://doi.org/10.1038/s41598-019-56300-6
www.nature.com/scientificreportswww.nature.com/scientificreports/
also showed a lack of induction, or even reduced expression of inflammatory cytokines IFN-γ, IL-17a and TNF-α 
compared to H37Rv as early as 3 dpi (Fig. 6B–D). Especially for TNF-α, expression levels differed markedly 
between bone marrow cells from Beijing-1585- and H37Rv-infected mice over time with a decreased expression 
for Beijing-1585 at 14 dpi compared to 3 dpi, as opposed to a 34-fold increase for H37Rv. Measurement results 
for the EAI-1627 group consistently were intermediate between those for the Beijing-1585 and H37Rv groups.
Induction of type 1 IFN signature genes in the lungs of infected mice essentially correlates with 
expression of IFN-β. Since mycobacterial virulence has been associated with increased lung induction of 
type 1 interferons, we tested the mRNA expression of IFN-α genes (subtypes 1, 2, 5, 6 and 7) in the lungs in a 
similar approach as originally described by Manca et al.20. We found only a limited expression of the tested IFN-α 
genes at 3 dpi for all strains, which decreased upon progressing infection and showed no significant inter-strain 
differences (Fig. 7A).
IFN-α and IFN-β share the ability to bind to, and signal via the IFN-α/β receptor, therefore we evaluated 
IFN-β mRNA expression in the lungs. IFN-β expression in the H37Rv group was significantly higher than that in 
the EAI-1627 group at 3 dpi, and higher than that in the Beijing-1585 group, but without statistical significance 
(Fig. 7B).
Type I interferons comprise several more subtypes than those for which we could test expression by qPCR 
and their expression is often transient. Therefore we decided to test the type 1 interferon response, represented 
by expression of Mx1, IFI44 and CCL2, which are known type 1 interferon-inducible genes33–35. Expression levels 
of such genes can be combined into a type 1 interferon signature, which provides an indication of type 1 inter-
feron responsiveness in a tissue36. Our type 1 interferon signature showed different kinetics between Beijing-1585 
and H37Rv, with EAI-1627 again showing intermediate results (Fig. 7C, see Fig. S5 for individual graphs). Most 
notably, at 7 dpi the Beijing-1585 group showed the strongest induction of type 1 interferon-inducible genes in 
Figure 4. Myeloid cell populations in the lungs of mice infected with different Mtb strains. CD11b+ cells 
were classified as PMN (CD11b+Ly6Ghigh), iM/DC (CD11b+Ly6CintCD11chigh), monocyte-like cells (Mo-like) 
(CD11b+Ly6ChighCD11clow) and alveolar macrophages (AM) (CD11bintCD11chighSiglec-F+) in the lungs of mice 
infected with Beijing-1585 (black bars), EAI-1627 (open bars) or H37Rv (grey bars) compared to uninfected 
control mice (HC, striped bars). Gating strategies are shown in Fig. S5. (A) PMN cells showed a more rapid 
increase for Beijng-1585 and EAI-1627 compared to H37Rv. (B) iM/DC showed kinetics comparable to PMN 
for the different groups. (C) Monocyte-like cells are only higher in the EAI-1627 group at 14 dpi compared 
to the H37Rv group at 28 dpi. (D) Lung alveolar macrophages are lower in the Beijing-1585 and EAI-1627 
group compared to the H37Rv group at 14 dpi. N = 6 mice per group per time point, *p < 0.05, **p < 0.01, 
***p < 0.001 after Bonferroni correction.
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the lungs, while H37Rv-infected mice showed a higher peak induction at 14 dpi. The observed kinetics for the 
type 1 interferon-inducible genes at 7 dpi and 14 dpi closely matched the trends observed for IFN-β expression 
at these time points, and not IFN-α, except for the absence of a type 1 interferon signature in the lungs of mice 
infected with H37Rv at 3 dpi. This suggests that in this model IFN-β is more relevant for the induction of type 1 
IFN-regulated genes during acute infection than the tested IFN-α subtypes.
To compare the findings on IFN-β in the lungs at 3 dpi with differential systemic effects observed in the bone 
marrow, we measured IFN-β mRNA expression in the bone marrow. This showed a significantly increased expres-
sion of IFN-β in the H37Rv group compared to the Beijing-1585 group at 3 dpi (Fig. 7D). As such, the profile 
showed similarities to the expression of IFN-γ in bone marrow (Fig. 6C).
Discussion
We found that infection with the Mycobacterium tuberculosis Beijing-1585 strain or EAI-1627 strain is character-
ized by an influx of B-cells in the lungs and higher pulmonary IL-4 protein levels compared to a T cell-dominated 
response to the less virulent H37Rv strain. Beijing- or EAI-strain infection is also associated with recruitment of 
myeloid cells that appear functionally impaired with low IL-12 and iNOS expression levels. In addition, especially 
Beijing-1585 infection is associated with a reduced expression of inflammatory cytokines in the bone marrow 
compared to H37Rv-infected mice, as early as from 3 dpi onwards, suggesting disrupted priming of developing 
myeloid cells in favor of the mycobacteria.
Could the increased B-cell influx upon infection with clinical Mycobacterium tuberculosis strains contribute 
to the observed difference in virulence in our model? In chronic TB patients a protective role for B-cells and 
antibodies was recently demonstrated37,38. A study in non-human primates showed that B-cell depletion during 
acute infection resulted in lower levels of inflammation, but higher bacterial burdens39. We found that higher 
percentages of B-cells were associated with higher levels of inflammation, as expressed by inflammation markers 
TNF-α and IL-6, but also with higher bacterial burdens. In a mouse TB model of acute TB, B-cells were protective 
Figure 5. IL-12- and myeloid iNOS expression in the lungs of Mtb-infected mice. IL-12 mRNA expression 
in total lung homogenate as determined by qPCR (A,B) and iNOS expression assessed by flow cytometry in 
(C) alveolar macrophages (AM) and (D) inflammatory macrophages and dendritic cells (iM/DC) in the lungs 
of mice infected with Beijing-1585 (black bars), EAI-1627 (open bars) or H37Rv (grey bars) are compared to 
uninfected control mice (HC, striped bars). (A) IL-12p35 expression levels are lower in the Beijing-1585 group 
compared to the EAI-1627 and H37Rv group. (B) IL-12p40 expression is induced in EAI-1627- and H37Rv-
infected mice, and reached its peak for both strains at 14 dpi with higher expression in the H37Rv group. 
Beijing-1585 does not induce any notable expression of either IL-12p35 or IL-12p40 at all time points evaluated. 
(C) Only AM in the lungs of H37Rv-infected mice at 3,7 and 14 dpi show iNOS expression levels higher than 
observed in uninfected control mice. (D) also iM/DC in H37Rv-infected mice show higher iNOS expression 
than iM/DC in the lungs of mice from the Beijing-1585 or EAI-1627 group at all time points evaluated. N = 6 
mice per group per time point, *p < 0.05, **p < 0.01, ***p < 0.001 after Bonferroni correction. For experiments 
depicted in this figure, iM/DC were defined as CD11bhighCD11chighMHC-II+ cells and AM were defined as 
CD11bintCD11c+F4/80+CD200R+ cells (gating strategies: Fig. S4A), based on a distinct panel of antibodies. 
Population frequencies through this gating were highly comparable to those in Fig. 4 (Fig. S4B).
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as they reduced neutrophilia by limiting IL-17 responses40. We did find lower IL-17 protein levels in the lungs 
of Beijing-1585- and EAI-1627-infected mice compared to H37Rv at peak infection, but we observed a similar 
influx of PMN into the lungs. More recently it was shown that IL-17 and IL-17-producing innate lymphoid cells 
were protective during acute Mtb infection41–43. Our findings of higher IL-17 levels in the lungs of H37Rv-infected 
mice compared to Beijing-1585 and EAI-1627 are in accordance with this notion. Nevertheless, the exact role of B 
cells and potential involvement of IL-17 in this axis remains to be established.
Beijing-1585 and EAI-1627 infection elicited significant IL-4 protein levels in the lungs, thus matching the 
observed increase in B-cells. The presence of IL-4 was previously shown to exert a pathogenic effect during TB 
by diverting the role of TNF-α from myeloid cell activator to tissue damage mediator44. This is in line with obser-
vations by others that virulent Beijing strains induce higher IL-4 mRNA expression levels in the lungs of mice 
at 14 dpi compared to non-virulent Beijing strains24, and in vitro studies showing that Beijing-HN878 preferen-
tially induced IL-4 expression in human peripheral blood mononuclear cells compared to the CDC1551 strain45. 
Together with our observations, this adds to the support for a host-detrimental role of IL-4 and B-cell responses 
during acute infection in which IL-4 stimulates macrophages to express a non-bactericidal, alternatively activated 
phenotype. However, differential exposure of myeloid cells to IL-4 may not be decisive in pathogenesis, since sim-
ilar mortality, bacterial burden, histopathology and iNOS expression were observed after infection of wildtype or 
myeloid-specific IL-4Ralpha knockout mice with H37Rv or HN87846. The source of IL-4 during acute infection 
remains obscure as no notable T-cell responses were observed for Beijing-1585 and EAI-1627. Also eosinophil 
numbers, as another known source of IL-4 in the lungs, were not elevated in our study. Given the recently demon-
strated protective role of IL-17- producing group 3 ILC in TB43, it might be interesting to study the role of IL-4 
producing group 2 ILC during acute infection with Beijing or EAI strains.
Beijing-1585 induced lower lung IL-12p35 and IL-12p40 mRNA expression levels compared to H37Rv, which 
is in agreement with previous studies20,21,45,47. This might contribute to reduced T-cell responses given the role 
of IL-12 in this axis31,48. However, the differences in IL-12 expression between EAI-1627 and H37Rv were less 
pronounced and EAI-1627 infection still resulted in a B-cell response, making this a less likely explanation for the 
noticeable difference in lymphocyte response. iNOS-expression levels in AM and iM/DC were reduced both in 
mice infected with Beijing-1585 and EAI-1627 compared to H37Rv, consistent with previous studies15,24,49. Low 
iNOS expression was previously shown to be associated with low expression levels of IFN-γ and TNF-α mRNA32. 
Remarkably, we observed that lower iNOS expression by iM/DC was accompanied with higher IFN-γ and TNF-α 
Figure 6. Cytokine mRNA expression levels in bone marrow of mice infected with different Mtb strains. 
Expression levels of target cytokine mRNA are shown relative to Gapdh in the bone marrow of mice infected 
with Beijing-1585 (black bars), EAI-1627 (open bars) or H37Rv (grey bars). (A) IL-12p35 expression at 3 
dpi and 7 dpi was lower in the Beijing-1585 group compared to H37Rv. (B) IFN-γ expression was lower for 
Beijing-1585 at 3 dpi compared to H37Rv. (C) IL-17a levels were markedly lower in the Beijing-1585 group 
compared to the H37Rv group (mean of 0.26 vs. 26.7), but without statistical significance (p = 0.06 after 
Bonferroni correction) due to the high spread in the H37Rv group (5.3–71.8). (D) TNF-α levels were higher in 
the bone marrow of H37Rv-infected mice compared to Beijing-1585-infected mice at all time points evaluated. 
EAI-1627 consistently showed intermediate results between Beijing-1585 and H37Rv for all cytokines. N = 6 
mice per group per time point, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 after Bonferroni correction.
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protein levels in the lungs of Beijing-1585- and EAI-1627-infected mice compared to H37Rv at 14 dpi. This low 
level iNOS expression in AM and iM/DC in the lungs despite high local IFN-γ protein levels could be due to inhi-
bition or prevention of iNOS induction at the site of infection. Alternatively, iNOS expression might be affected 
by differential priming of myeloid cells at an earlier stage of development.
In support of our hypothesis that differential priming might play a role we found that the expression of inflam-
matory cytokines such as IFN-γ and TNF-α in the bone marrow differs significantly between mice infected with 
different bacterial strains. Interestingly, this occurs already in the early stage of infection before widespread bac-
terial dissemination. While not conclusive, this suggests that differential bone marrow priming of myeloid cells 
might be an important shaping factor early during infection with Mycobacterium tuberculosis.
Next to differential expression of IFN-γ in the bone marrow, we found significant differences in type 1 inter-
feron expression and responses in both bone marrow and lung between Beijing-1585 and H37Rv. Previous studies 
have associated virulent Beijing-HN878 infection with elevated IFN-α mRNA expression in the lungs at 28 dpi in 
a low-dose BALB/c infection model19,20. We were unable to reproduce this preferential increase in IFN-α mRNA 
upon infection with the virulent Beijing strain in the lungs, which could be due to using a high-dose infection 
model and/or measurements at different time points. However, other parameters such as bacterial load kinetics 
and host responses in H37Rv infection in our model show strong similarities to low-dose (102 CFU) infection 
studies17,50 suggesting that strain-dependent virulence plays a dominant role in pathogenicity over bacterial load. 
Also, in our subsequent analysis of both generic type 1 interferon-inducible gene expression and pulmonary 
IFN-β expression we found generally lower expression levels after infection with Beijing-1585 and EAI-1627 
compared to H37Rv, thus questioning the direct association of Mycobacterium tuberculosis virulence with type 1 
interferon activity during acute infection.
Taken together, we show in a mouse TB model that infection with highly virulent clinical Beijing- and 
EAI-strains is associated with influx of B-cells and elevated IL-4 levels in the lungs, while less virulent H37Rv 
Figure 7. Expression of IFN-α, IFN-β and type 1 interferon-inducible genes in lung and bone marrow during 
infection with different Mtb strains. (A) Combined expression of IFN-α 1,2,5,6,7 mRNA in lung homogenate 
did not show significant differences between groups. No expression could be detected in uninfected mice (N/A). 
(B) Expression of IFN-β mRNA in lung homogenate was higher in the lungs of H37Rv-infected mice compared 
to EAI-1627-infected mice at 3 dpi. Other differences did not reach significance. (C) Combined expression in 
the lungs of type 1 interferon-inducible genes Mx1 (black), IFI44 (light grey) and CCL2 (dark grey), represented 
in a type 1 interferon signature, showed the highest level in the Beijing-1585 group at 7 dpi and in the H37Rv 
group at 14 dpi. For individual expression levels see Fig. S6. (D) Expression of IFN-β in the bone marrow is 
higher in the H37Rv group compared to Beijing-1585 at 3 dpi. N = 6 mice per group per time point, *p < 0.05, 
**p < 0.01, ***p < 0.001 after Bonferroni correction. Two-way, repeated measure ANOVA followed by 
Bonferroni correction was used to calculate significance for C.
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bacteria induce T-cell influx and higher IFN-γ and IL-17a levels at peak infection. Induction of iNOS is hampered 
in lung-infiltrating myeloid cells, especially in Beijing-infected mice. A significantly reduced expression in the 
bone marrow of IFN-γ, TNF-α and IFN-β, early in infection with virulent clinical Mtb strains, might contribute 
to this poor responsiveness of myeloid cells recruited in the lungs.
Materials and Methods
Mycobacterial strains. We used the Mycobacterium tuberculosis H37Rv strain (ATCC 27294) belonging to 
the Euro-American lineage and two strains isolated from patients in Vietnam in 2002, Beijing-1585, and EAI-
1627, as representatives for their respective lineage based on genotyping results27.
Mice and infection. Female specific pathogen-free BALB/c mice aged 10–11 weeks and weighing 22–24 
grams (Charles River, Les Oncins, France) were infected by intratracheal instillation under general anesthesia as 
described previously25. Inoculum sizes were confirmed by plating and were 1.0.105 colony forming units (CFU) 
for Beijing-1585, 1.3.105 CFU for EAI-1627 and 1.8.105 CFU for H37Rv. Mice infected with Beijing-1585 or 
EAI-1627 rapidly become moribund between 3–5 weeks18, therefore mycobacterial loads and other parame-
ters for these two clinical strains were measured up to the peak of infection at 14 dpi, while measurements on 
H37Rv-infected animals were continued up to peak of infection at 28 dpi.
ethics statement. All protocols were approved by the Erasmus MC institutional animal ethics commit-
tee (DEC number 117-12-13, EMC-number 3005) and adhered to the rules laid down in the Dutch Animal 
Experimentation Act and the EU Animal Directive 201/63/EU. All methods were performed in accordance with 
the relevant guidelines and regulations. The Beijing-1585 and EAI-1627 mycobacterial strains are part of the 
sample collection of the National Tuberculosis Reference Laboratory, National Institute of Public Health and the 
Environment (RIVM, Bilthoven, the Netherlands).
Determination of mycobacterial load. Lungs and spleens were removed aseptically and homogenized in 
2 mL PBS using the gentleMACS Octo Dissociator (Miltenyi Biotec BV, Leiden, the Netherlands) according to the 
manufacturer’s protocol. From each tissue homogenate 10-fold serial dilutions were made in PBS. Next, 200 µL 
aliquots were plated on 7H10 agar culture plates supplemented with 10% OADC. Plates were incubated for up to 
42 days at 37 °C and 5% CO2 before colonies were counted.
flow cytometry. The flow cytometry protocol, fluorescent antibody panels, real-time quantitative PCR and 
cytokine assessments were essentially as described previously51. Briefly, lung single-cell suspensions were fixed for 
30 min in fix/perm solution (Ebioscience, Vienna, AT) to eliminate live bacteria prior to flow cytometry analysis. 
Next, cells were washed and incubated for 10 min in permeabilization buffer (Ebioscience) and then incubated 
for 30 min with different mAb mixes as described Supplementary Table 1. After staining, the cells were washed 
again, resuspended in PBS/BSA/azide buffer and measured on a FACS Canto II flow cytometer (BD Biosciences, 
Breda, NL).
Real-time quantitative PCR. RNA from mouse lung homogenate was purified and processed as described 
previously51. Primer sequences and manufacturers are listed in Supplementary Table 2.
Cytokine protein levels. To determine cytokine levels in the lungs, lung homogenate was placed in a 
low-adhesion tube (USA Scientific, Orlando, FL, USA) and centrifuged at 10.000 × g for 5 min. The supernatant 
was collected, placed in an Eppendorf tube with a 0.45 μm filter (Corning BV Life Sciences, Amsterdam, NL) 
and centrifuged again at 10.000 × g for 5 min to filter out all mycobacteria. IFN-γ, TNF-α, IL-4, IL-6, IL-17a, 
IL-23 and IL-10 concentrations were measured in the filtrate using a Luminex assay according to manufacturer’s 
instructions (Merck Millipore, Amsterdam, NL).
Data analysis and statistics. Flow cytometry data were analyzed using Flowjo 7.6.5. Analyses were done 
and graphs were made using PRISM GraphPad 7. All data are expressed as mean ± SEM. Student’s t-test, followed 
by Bonferroni correction for multiple comparisons where applicable, was used to calculate significance, except for 
Fig. 7B. Here we used two-way, repeated measure ANOVA. P-values less than 0.05 were considered statistically 
significant.
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